Increased revascularization efficacy after administration of an adenovirus encoding VEGF(121). (Q30758542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

title

Increased revascularization efficacy after administration of an adenovirus encoding VEGF(121) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

author name string

Perrin LA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

June JE

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Rosebury W

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Robertson A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Bruder JT

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Kessler PD

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Keiser JA

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Gordon D

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

512-521

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14999223%20AND%20SRC:MED&resulttype=core&format=json

Adenoviruses as gene-delivery vehicles

24 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Gene therapy using adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Enzyme-linked immunosorbent assay (ELISA) for detecting antibodies in sera of patients with adenovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Effective repeat administration with adenovirus vectors to the muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Current strategies in the diagnosis and management of lower extremity peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

7 January 2021

"Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

7 January 2021

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

7 January 2021

Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

7 January 2021

Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

7 January 2021

VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

7 January 2021

Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

7 January 2021

Age-dependent effects of repeated immunization with a first generation adenovirus vector on the immune response and transgene expression in young and old rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302173

7 January 2021